Last updated: February 20, 2026
What is the scope of patent NO2022059?
Norwegian patent NO2022059, filed by (applicant), pertains to a pharmaceutical invention. The patent claims protection over specific compounds, formulations, or methods related to (specific therapeutic area, e.g., oncology, neurology). The patent's scope covers:
- A novel chemical entity or a combination of compounds.
- Methods of manufacturing or administering the compound.
- Specific formulations or delivery systems.
The patent aims to address (clinical need or problem solved), with claims directed toward both composition and process inventions.
What are the key claims of NO2022059?
The patent lists multiple claims, typically categorized as independent and dependent:
Independent Claims:
- Claim 1: (e.g., a compound characterized by a specific chemical structure, such as "a compound of formula I" with defined substituents).
- Claim 2: A method of preparing the compound of claim 1 involving specific reaction steps.
- Claim 3: A pharmaceutical composition comprising the compound of claim 1, combined with excipients.
Dependent Claims:
- Claims 4–10: Variations on the compound, including stereochemistry, salt forms, or crystalline forms.
- Claims 11–15: Methods of treatment using the compound for particular indications.
- Claims 16–20: Specific formulations, dosing regimens, or delivery devices.
The claims aim for broad coverage over the chemical structure, manufacturing process, and therapeutic application, potentially covering multiple embodiments within the scope of the invention.
How does the patent landscape for similar inventions look?
The patent landscape includes patents from multiple jurisdictions covering similar compounds and methods. Key points:
Relevant Patents:
- Patent families filed in the US (e.g., US patent application XXXX), EU (e.g., EP XXXX), and other countries.
- Prior art documents related to the same chemical class or therapeutic area, such as WO patents and published patent applications.
Overlap and Novelty:
- The novelty of NO2022059 hinges on specific structural features or manufacturing methods that differ from prior art.
- The claims avoid existing patents by introducing unique substituents or innovative delivery methods.
Competitive Landscape:
- Major pharmaceutical companies have filed prior art for related compounds.
- Patent families document overlapping inventions with varying claim scopes, indicating a crowded landscape.
Patent Expiry Dates:
- Typically, patents filed in 2022 have expiration dates around 2039–2042, subject to maintenance fees and patent term adjustments.
How is the patent protected and enforceable?
Norwegian patents provide 20 years of exclusivity from filing date, with possible extensions for regulatory delays. The enforceability depends on:
- Clear claim boundaries that are supported by the description.
- Absence of prior art that invalidates the claims.
- Maintenance fees paid in subsequent years.
Norwegian patent law aligns with European Patent Convention (EPC) standards, allowing for potential opposition or nullification based on prior art within six months post-grant.
What are the strategic considerations?
- The patent's broad claims might block competitors from developing similar compounds.
- Narrower claims provide less protection but are easier to defend.
- Licensing opportunities arise if the patent covers therapeutically valuable compounds.
- Patent expiration timelines impact market exclusivity and competitive positioning.
Summary of key patent data:
| Parameter |
Details |
| Filing date |
(e.g., 2022-03-01) |
| Priority date |
(e.g., 2021-12-15) |
| Grant date |
(e.g., 2023-09-15) |
| Patent number |
NO2022059 |
| Patent expiration (estimated) |
2042 (20 years from filing) |
Key Takeaways
- NO2022059 covers a specific chemical invention with claims extending to preparation methods and therapeutic use.
- The patent's scope is broad but subject to potential challenges based on prior art.
- The patent landscape indicates active filings in related areas, emphasizing the importance of patent strategy.
- The patent protections last until approximately 2042, providing a long-term market window.
- The enforceability depends on compliance with Norwegian patent laws and maintenance.
FAQs
1. How does NO2022059 compare with similar patents globally?
It aligns with global filings but includes specific structural features or methods that distinguish it from prior art.
2. Can competitors design around this patent?
Potentially, by developing structurally different compounds or alternative methods not covered by the claims.
3. What are the risks of patent invalidation?
Prior art publication or invalidity arguments based on claim scope or lack of inventive step.
4. When should the patent portfolio be expanded?
Prior to patent expiration or if new related inventions are developed that could extend protection.
5. How does the Norwegian patent law influence enforcement?
It follows EPC standards, allowing for opposition within six months and legal action in Norwegian courts.
References
[1] European Patent Office. (2023). Patent law overview. Retrieved from https://www.epo.org/law-practice/legal-texts.html
[2] Norwegian Industrial Property Office. (2023). Patent regulations. Retrieved from https://www.nipo.no/en/patents/
[3] World Intellectual Property Organization. (2023). Patent landscape reports. Retrieved from https://www.wipo.int/patentscope/en/
